Non-Alcoholic Steatohepatitis Market by 2025 Major Players - Allergan, Cadila Healthcare, Conatus, Galmed, Novartis

Nonalcoholic steatohepatitis (NASH) is a common liver disease commonly referred to as silent liver disease. Late stages are asymptomatic and many patients do not know their condition. NASH is expected to cause liver transplantation in the United States in the next few years. NASH prevalence, pipeline drug launches, and unmet demand growth were key market drivers.

However, NASH 's poor diagnosis due to lack of ideal diagnostic technology limits NASH market growth. The global non-alcoholic steatohepatitis (NASH) market was valued at $1,179 million in 2017, and is expected to reach $21,478 million by 2025, growing at a CAGR of 58.4% from 2021 to 2025.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/224?utm_source=openpr_ss

Currently, there are no FDA-approved medicines sold in the market for the treatment of NASH. Lifestyle mediation is the first approach to managing NASH patients. Depending on the drug type, the market is classified as vitamin E & pioglitazone, ocaliva, elafibranor and selonsertib & cenicriviroc. Vitamin E and pioglitazone contribute significantly to the effects of alopecia, inflammation, hepatocyte swelling and scarring in patients with NASH.

Based on sales channels, the market is divided into hospital pharmacies, online providers and retail pharmacies. Currently, the retail pharmacy sector is considered a dominant source of revenue and is dominant over the forecast period due to patient convenience and the impact of retail pharmacies around the world. However, online pharmacies are expected to show the fastest market growth due to increased awareness of online pharmacies and increased preference for online drug purchases as compared to traditional methods.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/224?utm_source=openpr_ss

Leading Companies:

•Allergan plc. (Tobira Therapeutics)
•Cadila Healthcare Limited
•Conatus Pharmaceuticals Inc.
•Galmed Pharmaceuticals Ltd

Key Findings of the Non-alcoholic Steatohepatitis Market :

•Based on drug type, the selonsertib & cenicriviroc segment is expected to exhibit the fastest market growth, is projected to grow at a CAGR of 73.7% from 2021 to 2025.

•Based on sales channel, the retail pharmacy segment held more than half of the global market share in 2017 and is expected to remain dominant throughout the forecast period.

•Based on sales channel, the online provider segment exhibited fastest growth and is anticipated to grow at a CAGR of 63.2% from 2021-2025.

•Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 62.62% during the forecast period.

Browse More Details of Report @ https://www.alliedmarketresearch.com/nonalcoholic-steatohepatitis-nash-market?utm_source=openpr_ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.